Efficacy of nivolumab and ipilimumab in patients with hepatocellular carcinoma with prior immune-checkpoint inhibitor treatment.

被引：0
|
作者：
Cheon, Jaekyung
Kang, Beodeul
Jung, Sang-Hoon
Kim, Chan
Chon, Hongjae
机构：
[1] CHA Univ, Sch Med, CHA Bundang Med Ctr, Med Oncol,Dept Internal Med, Seongnam, South Korea
[2] CHA Univ, CHA Bundang Med Ctr, Med Oncol, Seongnam, South Korea
[3] CHA Bundang Med Ctr, Seongnam Si, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
554
引用
下载
收藏
页码：554 / 554
页数：1
相关论文
共 50 条
  • [31] Recurrent malignant peritoneal mesothelioma: Is immune checkpoint inhibitor-related treatment with Nivolumab und Ipilimumab an option?
    Auletta, V
    Esber, A.
    Abu, Dakah T.
    Kather, A.
    Runnebaum, I. B.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E45 - E45
  • [32] Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
    Maki Todo
    Yodo Gatate
    Shintaro Nakano
    Go Kaneko
    Masayuki Hagiwara
    Takayuki Takahashi
    Yuta Umezawa
    Genji Ueda
    Shiho Ishikawa
    Yoshinori Makino
    Masafumi Oyama
    Suguru Shirotake
    Cancer Immunology, Immunotherapy, 74 (3)
  • [33] Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
    Personeni, Nicola
    Pressiani, Tiziana
    D'Alessio, Antonio
    Prete, Maria Giuseppina
    Bozzarelli, Silvia
    Terracciano, Luigi
    Dal Buono, Arianna
    Capogreco, Antonio
    Aghemo, Alessio
    Lleo, Ana
    Lutman, Romano Fabio
    Roncalli, Massimo
    Giordano, Laura
    Santoro, Armando
    Di Tommaso, Luca
    Rimassa, Lorenza
    CANCERS, 2021, 13 (22)
  • [34] Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab
    Schnickel, Gabriel T.
    Fabbri, Kassandra
    Hosseini, Mojgan
    Misel, Michael
    Berumen, Jennifer
    Parekh, Justin
    Mekeel, Kristin
    Dehghan, Yalda
    Kono, Yuko
    Ajmera, Veeral
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (06) : 1699 - 1704
  • [35] Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma
    Pomej, Katharina
    Balcar, Lorenz
    Sidali, Sabrina
    Sartoris, Riccardo
    Meischl, Tobias
    Trauner, Michael
    Mandorfer, Mattias
    Reiberger, Thomas
    Ronot, Maxime
    Bouattour, Mohamed
    Pinter, Matthias
    Scheiner, Bernhard
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024,
  • [36] Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma?
    Lee, Choong-kun
    Chan, Stephen L.
    Chon, Hong Jae
    CANCERS, 2022, 14 (13)
  • [37] Immune profiling for improving responsiveness to ipilimumab plus nivolumab checkpoint blockade treatment in patients with metastatic melanoma
    Baginska, Joanna
    Chen, Jiajia
    Tarantino, Giuseppe
    Giobbie-Hurder, Anita
    Weirather, Jason L.
    Severgnini, Mariano
    Manos, Michael
    Burke, Kelly
    Russell, Janice D.
    Brainard, Martha
    Gabriel, Elizabeth
    Brennick, Ryan
    Nazzaro, Matthew
    Hathaway, Emma
    Holovatska, Marta
    Manuszak, Claire
    Ranashinge, Srinika
    Liu, David
    Hodi, F. Stephen
    CANCER RESEARCH, 2023, 84 (06)
  • [38] Poor efficacy of immune checkpoint inhibitor treatment in advanced thymic carcinoma patients with liver metastases
    Hao, Yue
    Xu, Manyi
    Zeng, Xiaohong
    Wang, Yina
    Wang, Wenxian
    Lin, Gen
    Li, Bihui
    Huang, Jianhui
    Xu, Chunwei
    Zhang, Yongchang
    Song, Zhengbo
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [39] A phase II clinical trial to study the efficacy of cabozantinib in patients with hepatocellular carcinoma refractory to immune checkpoint inhibitor-based treatment
    Chan, S.
    Ryoo, B-Y.
    Mo, F.
    Cheon, J.
    Li, L.
    Wong, K. H.
    Nicole, Y.
    Kim, H.
    Yoo, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S1454 - S1454
  • [40] Immune-checkpoint therapy resistance by tumor-intrinsic evolution in hepatocellular carcinoma
    Xiong, Zhewen
    Zhou, Jingying
    Cao, Jianquan
    Vong, Joaquim
    Zeng, Xuezhen
    Tu, Yalin
    Feng, Yu
    Cheng, Alfred
    CANCER SCIENCE, 2021, 112 : 436 - 436
12345